FDA approval for Lilly’s weekly insulin Onswik, shares dip

{
  "signal_id": "b297b7e4-ea9f-d944-5085-313885c60700",
  "signal_type": "news",
  "signal_subtype": "has_earnings",
  "detected_at": "2026-09-24T13:50:42+00:00",
  "company": {
    "name": "Eli Lilly",
    "domain": "lilly.com"
  },
  "data": {
    "url": "https://www.financial-news.co.uk/fda-approval-for-lillys-weekly-insulin-onswik-shares-dip/",
    "title": "FDA approval for Lilly’s weekly insulin Onswik, shares dip - Financial-News.co.uk",
    "excerpt": "The US Food and Drug Administration has approved Eli Lilly’s (NYSE: LLY) once-weekly insulin Onswik for adults with type 2 diabetes, the company said on 24 September 2026. It is the fourth global approval for the drug, insulin efsitora alfa-gobe, following clearances from regulators in the European Union, Mexico and Japan, according to HCPLive . Onswik is designed to hold basal insulin levels steady over a full week, replacing the daily jabs most basal insulin users currently need. Lilly says the product could cut a patient’s basal injections from roughly 365 a year to 52, per HCPLive . The clearance rests on the QWINT Phase 3 programme, which tested the drug in more than 3,400 adults with type 2 diabetes across four registration studies, Lilly said in its investor release. Each trial met its primary goal of reducing A1C by a margin non-inferior to insulin glargine U-100 or degludec U-100, according to PharmExec . ‘For over a century, Lilly has been developing insulins that transformed diabetes care for millions of people worldwide, but delays in initiating treatment and the burden of daily injections can have a real impact on patients’ day-to-day experience managing type 2 diabetes,’ said Kenneth Custer, executive vice president and president of Lilly Cardiometabolic Health, in a statement republished by BioSpace . The approval was also reported independently by Reuters...",
    "summary": "Eli Lilly reported net income of $7.1bn for the second quarter of 2026.",
    "planning": false,
    "image_url": "https://www.financial-news.co.uk/wp-content/uploads/2026/09/price-1m-83.png",
    "confidence": 0.8,
    "published_at": "2026-09-24T13:50:42Z",
    "article_sentence": "Lilly reported $7.4bn in net income for the first quarter of 2026 and $7.1bn for the second quarter, up from $2.76bn and $5.66bn respectively a year earlier, the filings show.",
    "amount_normalized": 7100000000
  }
}

curl https://signals.autobound.ai/v1/signals/b297b7e4-ea9f-d944-5085-313885c60700 \
  -H "X-API-KEY: $AUTOBOUND_API_KEY"

curl -X POST https://signals.autobound.ai/v1/companies/enrich \
  -H "X-API-KEY: $AUTOBOUND_API_KEY" \
  -H "Content-Type: application/json" \
  -d '{"domain":"lilly.com","limit":20}'